About this trial
The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female or Male patients ≥30 and ≤55 years old
Bilateral hearing loss first noticed after the age of 16 years old
Documented genotyping results showing mutations in GJB2 gene.
Disqualifiers
Deafness with a known, non-genetic cause
To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures
Trial population
Male and female participants aged ≥30 and ≤55 years old with bilateral hearing loss first noticed after the age of 16 years old.
Trial design
Other
Other
Treatments tested in this trial
Genotyping
GeneticGenotyping to determine if patients present mutations to the gene GJB2.
Audiological assessments
Other interventionAudiological assessments
Treatment groups
Trial outcomes
Primary outcomes
Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene.
Evolution of hearing impairment assessed by Pure Tone Audiometry
Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene
Evolution of hearing impairment assessed by Speech in noise
Secondary outcomes
Genetic characteristics of adult patients with early-onset presbycusis
Genotyping
Audiological characteristics of adult patients with early-onset presbycusis
Pure Tone Audiometry
Mood evaluation in adult patients with early-onset presbycusis carrying mutations in GJB2 gene
Mood evaluation assessed with Patient Health Questionnaire for depression (PHQ-9)